Warning: The excedrin migraine warning label is inadequate to warn consumers of the risk of medication rebound headache [1] (multiple letters)

Randolph Evans, H. D. Hoffman

Research output: Contribution to journalLetterpeer-review

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)679-680
Number of pages2
Issue number9
StatePublished - Dec 20 1999

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this